Similar Search Results

Strategic corporate social responsibility and orphan drug development : insights from the US and the EU biopharmaceutical industry

Bruyaka, Olga; Zeitzmann, Hanko K.; Chalamon, Isabelle; … - In: Journal of business ethics : JOBE 117 (2013) 1, pp. 45-65

Persistent link: https://www.econbiz.de/10010231737

The impact of public basic research on industrial innovation : evidence from the pharmaceutical industry

Toole, Andrew A. - 2011 - This version: March 2011

While most economists believe that public scientific research fuels industry innovation and economic growth, systematic … size as a significant driver of drug innovation in the pharmaceutical industry, but they did not find any evidence … supporting science-driven innovation from publicly funded research. This paper uses new data on biomedical research investments …

Persistent link: https://www.econbiz.de/10009374417

Calculating the Costs and Benefits of Advance Preparations for Future Pandemics

Glennerster, Rachel; Snyder, Christopher M.; Tan, … - National Bureau of Economic Research - 2022

The Covid-19 pandemic is estimated to have caused over 7 million deaths and reduced economic output by over $13 trillion to date. While vaccines were developed and deployed with unprecedented speed, pre-pandemic investments could have accelerated their widespread introduction, saving millions of...

Persistent link: https://www.econbiz.de/10013435127

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017

Persistent link: https://www.econbiz.de/10011708133

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...